Phosphorus-containing compounds
US-2019374441-A1 · Dec 12, 2019 · US
US9689877B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9689877-B2 |
| Application number | US-201515112395-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 16, 2015 |
| Priority date | Jan 16, 2014 |
| Publication date | Jun 27, 2017 |
| Grant date | Jun 27, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compounds useful as fluorescent or colored dyes are disclosed. The compounds have the following structure (I): Formula (I), including stereoisomers, salts and tautomers thereof, wherein R 1a , R 1b , R 2a , R 2b , R 2c , R 2d , R 2e , R 2f , R 2g , R 2h , R 2i , R 2j , R 2k , R 2l , R 2m , R 2n , R 2o , R 2p , R 2q , R 2r and R 2s are as defined herein. Methods associated with preparation and use of such compounds are also provided.
Opening claim text (preview).
What is claimed is: 1. A compound having the following structure (I): or a salt, stereoisomer or tautomer thereof, wherein: R 1a and R 1b are each independently hydroxyl or alkoxy; and R 2a , R 2b , R 2c , R 2d , R 2e , R 2f , R 2g , R 2h , R 2i , R 2j , R 2k , R 2l , R 2m , R 2n , R 2o , R 2p , R 2q , R 2r , R 2s and R 2t are each independently H, halo or -L 1 -R 3 ; R 3 is, at each occurrence, independently an analyte molecule or alkyl substituted with one or more of hydroxyl, protected hydroxyl, amino, alkylamino, alkoxy, polyalkyether, hydroxylalkoxy, aminoalkoxy, hydroxylpolyalkyether, aminopolyalkyether, phosphate, thiophosphate, phospho, thiophospho, phosphoalkylether, Ophosphoalkylether, thiophosphoalkylether, Othiophosphoalkylether, phosphoramidite or activated phosphorous; or R 3 is a microparticle; and L 1 is an optional linker moiety. 2. The compound of claim 1 , wherein the compound has the following structure: 3. The compound of claim 1 , wherein the compound has the following structure (If): 4. The compound of claim 1 , wherein R 1a or R 1b is hydroxyl. 5. The compound of claim 1 , wherein R 1a or R 1b , or both, is alkoxy. 6. The compound of claim 1 , wherein at least one of R 2a , R 2b , R 2c , R 2d , R 2e , R 2f , R 2g or R 2h is halo. 7. The compound of claim 6 , wherein R 2b is bromo. 8. The compound of claim 1 , wherein at least one of R 2a , R 2b , R 2c , R 2d , R 2e , R 2f , R 2g or R 2h is -L 1 -R 3 . 9. The compound of claim 8 , wherein R 2b is -L 1 -R 3 . 10. The compound of claim 1 , wherein R 3 is, at each occurrence, independently alkyl substituted with one or more of hydroxyl, protected hydroxyl, amino, alkylamino, alkoxy, polyalkyether, hydroxylalkoxy, aminoalkoxy, hydroxylpolyalkyether, aminopolyalkyether, phosphate, thiophosphate, phospho, thiophospho, phosphoalkylether, Ophosphoalkylether, thiophosphoalkylether, Othiophosphoalkylether, phosphoramidite or activated phosphorous. 11. The compound of claim 10 , wherein R 3 has, at each occurrence, independently one of the following structures: wherein: n 1 , n 2 and n 3 are each independently an integer from 1 to 6; and x and y are each independently an integer from 1 to 10. 12. The compound of claim 1 , wherein R 3 is, at each occurrence, independently an analyte molecule. 13. The compound of claim 12 , wherein the analyte molecule is a nucleic acid, peptide, carbohydrate, lipid, enzyme, receptor, receptor ligand, antibody, glycoprotein, aptamer, antigen, prion, drug, vitamin or small molecule. 14. The compound of claim 1 , wherein L 1 comprises a phosphate bond to the analyte molecule. 15. The compound of claim 14 , wherein L 1 has the following structure: wherein n 1 , n 2 and n 3 are each independently an integer from 1 to 6. 16. The compound of claim 1 , wherein the compound has one of the following structures: wherein R 3 is an analyte molecule. 17. The compound of claim 1 , wherein the compound has the following structure (Ib): 18. The compound of claim 1 , wherein the compound has the following structure (Ic): 19. The compound of claim 1 , wherein the compound has the following structure (Id): 20. The compound of claim 1 , wherein the compound has the following structure (Ie): 21. The compound of claim 1 , wherein R 2a , R 2b , R 2c , R 2d , R 2e , R 2f , R 2g , R 2h , R 2i , R 2j , R 2k , R 2l , R 2m , R 2n , R 2o , R 2p , R 2q , R 2r , R 2s and R 2t are each H. 22. The compound of claim 1 , wherein R 2a , R 2b , R 2c , R 2d , R 2e , R 2f , R 2g , R 2h , R 2i , R 2j , R 2k , R 2l , R 2m , R 2n , R 2o , R 2p , R 2q , R 2r and R 2s are each independently H, halo or -L 1 -R 3 , and R 2t is H.
Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53) · CPC title
of hydroxyalkyl compounds · CPC title
Polyol derivatives esterified at least twice by phosphoric acid groups · CPC title
with arylalkanols · CPC title
with non-fluorescent dye label · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.